Skip to main content

Table 8 Number of patients showing improvements based on age of the patients 6 months after cellular therapy

From: An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability

Characteristic

Mild improvement

Moderate Improvement

Significant improvement

Age

   

<18 years (paediatric)

1

3

13

≥18 years (adult)

1

3

8